|
Biotron Limited - Company Profile Snapshot
| Company Profile: |
Biotron Limited |
| Ticker: |
BIT |
| Exchanges: |
SYD |
| 2009 Sales: |
n/a |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
AUSTRALIA |
| Employees: |
4 |
Business Description
Biotron Limited. The Company's principal activities are funding and managing intermediate and early applied biotechnology research and development projects. It has been involved in the commercial development of two major projects, Virion and C-Test. The Virion Project is aimed at developing antiviral agents that will interact with viral proteins in several significant viral diseases such as the SARS coronavirus, Hepatitis C virus, Dengue virus and a number of viruses that cause the common cold as well as the anti-HIV program that it is currently developing. The C-Test project is developing sensitive, rapid, non-invasive assays to detect and diagnose specific types of cancer. It operates in Australia.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
